Key result
Plasma NT-proBNP levels were independently associated with the severity of angiographic coronary artery disease and demonstrated the highest diagnostic accuracy among tested biomarkers with an AUC of 0.69.
Why the study?
Does NT-proBNP level correlate with the severity of angiographic coronary artery disease in diabetic and pre-diabetic patients?
Cross-Sectional (n=415)
No
Does NT-proBNP level correlate with the severity of angiographic coronary artery disease in diabetic and pre-diabetic patients?
Effect estimate: AUC 0.69
Plasma NT-proBNP is a strong independent predictor of angiographic coronary artery disease severity and may be useful for CHD screening in diabetic and pre-diabetic patients.
Supports NT-proBNP evaluation for CAD severity in diabetes; hypothesis-generating and should not yet change screening practice.
BACKGROUND: Little is known about the plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), and the relationship between the severity of coronary heart disease (CHD) with NT-proBNP and multiple biomarkers in diabetic and pre-diabetic patients, compared to individuals with normal glucose levels. METHODS: Four hundred and fifteen consecutive Chinese patients of both sexes were assigned to three groups on the basis of the new hemoglobin (Hb) A1c (HbA1c) cut-off points for diagnosis of diabetes and pre-diabetes. The three groups were divided into tertiles according to NT-proBNP, hs-CRP, cystatin C, and troponin T levels. Gensini scores were compared among the three groups and biomarker tertiles. Receiver operating characteristic (ROC) curves were used to obtain the angiographic CHD cut-off points for each biomarker. Stepwise multivariate linear correlation analysis was applied to examine the association between the severity of CHD and biomarker levels. RESULTS: Gensini scores increased with increasing biomarker tertile levels and HbA1c. Gensini scores were significantly different in the middle and upper NT-proBNP tertiles of the diabetic, pre-diabetic and control groups. NT-proBNP had the highest positive and negative predictive values and area under the curve for CHD. Only NT-proBNP was identified as an independent variable for Gensini score. CONCLUSIONS: Plasma NT-proBNP may be an important biomarker to evaluate the severity of CHD and screen for CHD in diabetic or pre-diabetic patients.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2011) conducted a cross-sectional in Suspected myocardial ischemia / Coronary artery disease (n=415). NT-proBNP vs. Other biomarkers (troponin T, hs-CRP, cystatin C) was evaluated on Diagnostic accuracy for angiographic coronary heart disease (AUC 0.69). Plasma NT-proBNP levels were independently associated with the severity of angiographic coronary artery disease and demonstrated the highest diagnostic accuracy among tested biomarkers with an AUC of 0.69.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: